We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$976M
AUM Growth
+$257M
Cap. Flow
+$279M
Cap. Flow %
28.55%
Top 10 Hldgs %
76.43%
Holding
234
New
114
Increased
26
Reduced
16
Closed
77

Top Buys

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$370M
2
AIG icon
American International
AIG
+$8.49M
3
AMP icon
Ameriprise Financial
AMP
+$7.55M
4
TROW icon
T. Rowe Price
TROW
+$7.55M
5
V icon
Visa
V
+$6.43M

Top Sells

Rank Stock Value
1
JUNO
Juno Therapeutics, Inc.
JUNO
+$85.7M
2
FNB icon
FNB Corp
FNB
+$8.22M
3
TRV icon
Travelers Companies
TRV
+$7.78M
4
SHW icon
Sherwin-Williams
SHW
+$7.34M
5
WTW icon
Willis Towers Watson
WTW
+$7.28M

Sector Composition

Rank Sector Weight
1 Healthcare 37.59%
2 Financials 12.34%
3 Technology 4.43%
4 Industrials 4.41%
5 Consumer Discretionary 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
$349M 35.74%
7,631,631
-1,717,168
-18% -$85.7M
DNLI icon
2
Denali Therapeutics
DNLI
$3.65B
$322M 32.96%
+20,574,298
New +$370M
V icon
3
Visa
V
$684B
$12M 1.23%
104,896
+58,257
+125% +$6.43M
VOYA icon
4
Voya Financial
VOYA
$9.01B
$11M 1.12%
221,623
+81,920
+59% +$3.52M
NTRS icon
5
Northern Trust
NTRS
$22.4B
$10.2M 1.04%
102,074
+59,403
+139% +$5.66M
AMP icon
6
Ameriprise Financial
AMP
$48.3B
$10M 1.02%
58,996
+47,100
+396% +$7.55M
VRSK icon
7
Verisk Analytics
VRSK
$25.4B
$8.53M 0.87%
88,806
+40,562
+84% +$3.67M
AIG icon
8
American International
AIG
$41.7B
$8.23M 0.84%
+138,142
New +$8.49M
TROW icon
9
T. Rowe Price
TROW
$23.9B
$8.12M 0.83%
+77,365
New +$7.55M
RJF icon
10
Raymond James Financial
RJF
$33.8B
$7.49M 0.77%
125,723
+86,264
+219% +$4.97M
HIG icon
11
Hartford Financial Services
HIG
$38.9B
$6.83M 0.7%
121,411
+51,840
+75% +$2.89M
GPN icon
12
Global Payments
GPN
$23B
$5.13M 0.53%
51,160
+17,999
+54% +$1.8M
BRO icon
13
Brown & Brown
BRO
$23.6B
$4.99M 0.51%
+193,772
New +$4.87M
FDS icon
14
Factset
FDS
$9.36B
$4.93M 0.51%
+25,586
New +$4.91M
AGN
15
DELISTED
Allergan plc
AGN
$4.73M 0.48%
+28,930
New +$5.19M
AMT icon
16
American Tower
AMT
$80.8B
$4.64M 0.48%
+32,500
New +$4.64M
ORCL icon
17
Oracle
ORCL
$374B
$4.51M 0.46%
+95,500
New +$4.68M
ALXN
18
DELISTED
Alexion Pharmaceuticals
ALXN
$4.3M 0.44%
+35,973
New +$4.38M
CONE
19
DELISTED
CyrusOne Inc Common Stock
CONE
$4.17M 0.43%
+70,000
New +$4.25M
UNM icon
20
Unum
UNM
$13.6B
$3.9M 0.4%
+70,963
New +$3.81M
AFG icon
21
American Financial Group
AFG
$11.8B
$3.86M 0.4%
35,592
+13,807
+63% +$1.45M
CHL
22
DELISTED
China Mobile Limited
CHL
$3.71M 0.38%
+73,400
New +$3.69M
MS icon
23
Morgan Stanley
MS
$331B
$3.5M 0.36%
+66,635
New +$3.37M
EFX icon
24
Equifax
EFX
$20.3B
$3.35M 0.34%
+28,420
New +$3.19M
HAWK
25
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
$3.27M 0.34%
+91,869
New +$3.31M
1
2 3 4 5

Similar funds

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
NPCM
New Paradigm Capital Management Great Falls, Virginia $46.8M AUM
FCM
Firsthand Capital Management San Jose, California $46.9M AUM 114.33% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return
IPHI
Inflection Point Holdings II New York $47.3M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Crestline Management's Q4 2017 Portfolio in Review

As of Q4 2017, Crestline Management held 234 positions worth $976M, up 36% from $719M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Crestline Management deployed $279M of net new capital in Q4 2017, opening 114 new positions and adding to 26 existing holdings. Its largest new stake was Denali Therapeutics: 20,574,298 shares worth $322M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 5.7% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Juno Therapeutics, Inc., an estimated $85.7M trimmed.

  • Crestline Management's largest Q4 2017 buy was Denali Therapeutics: 20,574,298 shares worth $322M.
  • Crestline Management added most to Ameriprise Financial in Q4 2017, an estimated $7.55M increase.
  • Crestline Management's biggest Q4 2017 reduction was Juno Therapeutics, Inc., cutting an estimated $85.7M.
  • Crestline Management fully exited FNB Corp in Q4 2017, selling an estimated $8.22M.
  • Crestline Management's ten largest holdings make up 76% of its $976M portfolio in Q4 2017.
  • Crestline Management opened 114 new positions and closed 77 in Q4 2017.
  • Crestline Management's portfolio value rose 36% quarter-over-quarter to $976M.

Based on Crestline Management's 13F filing for Q4 2017, filed 14 Feb 2018.